Anti SARS-CoV 2 IgG antibody response in fully vaccinated Covishield (AZD1222) and Covaxin (BBV-152) recipients: a study done in southern part of West Bengal, India

BACKGROUND AND OBJECTIVES: Vaccination being the only way to reduce mortality from the dreaded COVID-19 disease, the vaccine was introduced in India as per the advice of the National Expert Group on January 16, 2021. Duration of immune response elicited by the vaccines has always been a matter of co...

Descripción completa

Detalles Bibliográficos
Autores principales: Satpathi, Partha Sarathi, Endow, Sayantani, Gantait, Kripasindhu, Chand, Pearl Helena, Jaiswal, Abhishek, Jana, Biswajit, Kundu, Panchanan, Ghosh, Tarapada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723424/
https://www.ncbi.nlm.nih.gov/pubmed/36531814
http://dx.doi.org/10.18502/ijm.v14i5.10953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723424/
https://www.ncbi.nlm.nih.gov/pubmed/36531814
http://dx.doi.org/10.18502/ijm.v14i5.10953

Ejemplares similares